Pharma Focus Asia

FRONTEO and Axcelead DDP Forge Essential AI-Enabled Drug Discovery Support Partnership

Monday, November 06, 2023

FRONTEO Co., Ltd. and Axcelead Drug Discovery Partners Co., Ltd. have recently entered into a foundational partnership agreement to enhance AI-driven support for drug discovery. FRONTEO specializes in the "Drug Discovery AI Factory" business, providing services that enhance the efficiency, speed, and success rates of drug discovery using their proprietary AI technology for generating hypotheses in drug research and development. In contrast, Axcelead DDP possesses the vital platform capabilities required for drug discovery and supports drug discovery research for various stakeholders, including pharmaceutical companies, bioventures, academic institutions, and government research bodies. This partnership agreement enables collaboration between FRONTEO's AI-driven hypothesis generation capabilities and Axcelead DDP's drug discovery platform in forming hypotheses through both dry research (computer and AI-based data analysis) and wet research (involving laboratory work with cells and animals). This collaborative approach allows for the efficient testing and validation of these hypotheses using biological experiments.

FRONTEO, expressed, "As we advance our Drug Discovery AI Factory business, we have received numerous requests from our client companies to handle the subsequent wet research required to validate the hypotheses derived from dry research. This partnership with Axcelead DDP will enable us to meet these demands and further contribute to the advancement of our clients' drug discovery research and the enhancement of healthcare quality. We are thrilled to be able to do this."

Axcelead DDP, stated, "We are delighted to strengthen our AI-based drug discovery support services through this partnership with FRONTEO, which excels in data analysis utilizing hypothesis-generating AI. By conducting wet research based on the drug discovery research expertise we have cultivated, we will significantly accelerate our clients' drug discovery efforts. As a platform company, we are committed to facilitating the development of innovative new drugs for our clients."

 

Source: fronteo.com

magazine-slider-imageMFA + MMA 2024CPHI Chine || PMEC China 2024Asia Healthcare Week 2024CPHI Korea 2024CHEMICAL INDONESIA 2024INALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024ISPE Singapore Affiliate Conference & Exhibition 2024Rehab Expo 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024LogiPharma Asia 2024